FDA Orange Book

Generic for Brevibloc

Brevibloc contains esmolol. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

Yes. The generic name for Brevibloc is esmolol. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP. Generics match 2 of the 3 Brevibloc products the Orange Book lists.

Run it in Rivvi

Map Brevibloc and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Brevibloc products in the Orange Book

Brevibloc products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
injectable, injection10MG/MLMarketed (Rx)AP4AP
injectable, injection10MG/MLDiscontinuedNone4AP
injectable, injection20MG/MLDiscontinuedNone0None

NDA 019386, held by BAXTER HEALTHCARE CORP. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic esmolol

Approved generic versions of Brevibloc
CompanyANDATE codeApprovedStrengths
HIKMA PHARMACEUTICALS USA INC076323AP (A-rated, therapeutically equivalent)August 10, 200410MG/ML, 10MG/ML
MYLAN INSTITUTIONAL LLC076474AP (A-rated, therapeutically equivalent)May 2, 200510MG/ML, 10MG/ML
EUGIA PHARMA SPECIALITIES LTD205520AP (A-rated, therapeutically equivalent)July 23, 201510MG/ML, 10MG/ML
GLAND PHARMA LTD208538AP (A-rated, therapeutically equivalent)August 14, 201910MG/ML, 10MG/ML

Brevibloc NDC codes

Questions

Is there a generic for Brevibloc?

Yes. The generic name for Brevibloc is esmolol. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP. Generics match 2 of the 3 Brevibloc products the Orange Book lists.

What is the generic name for Brevibloc?

The active ingredient in Brevibloc is esmolol, per the FDA Orange Book.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Brevibloc and Esmolol

Try it on your own data today.

Free to start. Most teams are using it the same day.